Issue link: https://www.e-digitaleditions.com/i/1469783
Inhalation June 2022 23 Comprehensive nasal formulation, development and manufacturing Catalent provides comprehensive nasal formula- tion, development and manufacturing services for liquid and powder, unit-dose and bi-dose nasal for- mats. Co-located with Catalent's analytical center- of- excellence, its inhalation business is equipped to provide end-to-end analytical support. For device vendor evaluation and selection, Catalent provides objective expertise to help identify the optimal deliv- ery format. With non-GMP and GMP facilities, including potent and controlled-drug handling, Catalent supports manufacturing services for both clinical- and commercial-scale. Catalent US: +1 888 SOLUTION (765-8846) www.catalent.com Semi- or fully automated testing systems Not only can you accurately control test variables such as air flow, firing force, speed and distance for dose wasting and collection, but each part of your semi- or fully automated testing system provides the traceable data needed for quality and compliance. Your 21 CFR Part 11 compliant data capture, storage and retrieval is available through our user friendly Relovex ® soft- ware. And your testing system can be installed as a standalone unit or integrated into Astech's full range of automated testing systems. Astech Projects UK: +44 1928 571797 www.astechprojects.co.uk Redesigned to increase its educational content, the Inhalation 1-2-3 e-newsletter provides a supplier's perspective on industry issues, highlights technical articles from the magazine and previews industry conferences. Please watch for it in your inbox every other month. Sign up now by emailing your name, company name and email address to subscriptions@inhalationmag.com. www.inhalationmag.com